Knowledge Resource Center for Ecological Environment in Arid Area
Construction of a Recombinant Allergen-Producing Probiotic Bacterial Strain: Introduction of a New Line for a Live Oral Vaccine Against Chenopodium album Pollen Allergy | |
Nasiraie, Leila Roozbeh; Tabatabaie, Farideh; Sankian, Mojtaba; Shahidi, Fakhri; Varasteh, Abdolreza | |
通讯作者 | Varasteh, A |
来源期刊 | REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
![]() |
ISSN | 2322-3480 |
出版年 | 2013 |
卷号 | 2期号:1页码:16-27 |
英文摘要 | Background: During the last two decades, significant advances have been made in the fields of lactococcal genetics and protein expression. Lactococcus lactis (L. lactis) is an effective vector for protein expression and can be used as an antigen delivery system. Hence, L. lactis is an ideal candidate for mucosal immunotherapy. Profilin (Che a 2), the major allergen in Chenopodium album, is one of the most important causes of allergic diseases in desert and semi-desert areas, especially in Iran, Saudi Arabia, and Kuwait that was cloned and expressed in L. lactis for the first time. Methods: To construct L. lactis that expressed Che a 2, a DNA sequence was cloned and used to transform bacteria. Expression of Che a 2 was analyzed via monitoring of related RNA and protein. Hydrophobicity, adherence to HT-29 cells, antibiotic resistance, resistance to gastrointestinal contents, pH, and bile salt in recombinant and native L. lactis were evaluated. Results: Immunoblot analyses demonstrated that recombinant Che a 2 is expressed as a 32 kDa dimeric protein immunological studies showed it can bind human IgE. Both native and recombinant bacteria were sensitive to low pH and simulated gastric conditions. Bacterial survival was reduced 80-100% after 2 h of exposure to pH 1.5-2. Both native and recombinant bacteria were able to grow in 0.3 and 2% bile salts. After incubation of recombinant L. lactis in simulated gastric and intestinal juices for one and two hours, respectively, cell survival was reduced by 100%. Adhesion capability in both strains was minimal and there were no significant differences in any of our tests between native and recombinant bacteria. Conclusion: Successfully recombinant L. lactis with capability of expression Che a 2 was produced and revealed it is sensitive to gastrointestinal contents. |
英文关键词 | Chenopodium pollen allergen Oral vaccines Probiotic bacteria Recombinant L. lactis |
类型 | Article |
语种 | 英语 |
开放获取类型 | DOAJ Gold |
收录类别 | ESCI |
WOS记录号 | WOS:000446893700002 |
WOS类目 | Biochemistry & Molecular Biology |
WOS研究方向 | Biochemistry & Molecular Biology |
资源类型 | 期刊论文 |
条目标识符 | http://119.78.100.177/qdio/handle/2XILL650/330605 |
作者单位 | [Nasiraie, Leila Roozbeh; Tabatabaie, Farideh; Shahidi, Fakhri] Ferdowsi Univ Mashhad, Dept Food Sci & Technol, Mashhad, Iran; [Sankian, Mojtaba] Mashhad Univ Med Sci, Sch Med, Immunol Res Ctr, Immunobiochem Lab, Mashhad, Iran; [Varasteh, Abdolreza] Mashhad Univ Med Sci, Sch Med, Allergy Res Ctr, Immunobiochem Lab, Mashhad, Iran |
推荐引用方式 GB/T 7714 | Nasiraie, Leila Roozbeh,Tabatabaie, Farideh,Sankian, Mojtaba,et al. Construction of a Recombinant Allergen-Producing Probiotic Bacterial Strain: Introduction of a New Line for a Live Oral Vaccine Against Chenopodium album Pollen Allergy[J],2013,2(1):16-27. |
APA | Nasiraie, Leila Roozbeh,Tabatabaie, Farideh,Sankian, Mojtaba,Shahidi, Fakhri,&Varasteh, Abdolreza.(2013).Construction of a Recombinant Allergen-Producing Probiotic Bacterial Strain: Introduction of a New Line for a Live Oral Vaccine Against Chenopodium album Pollen Allergy.REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY,2(1),16-27. |
MLA | Nasiraie, Leila Roozbeh,et al."Construction of a Recombinant Allergen-Producing Probiotic Bacterial Strain: Introduction of a New Line for a Live Oral Vaccine Against Chenopodium album Pollen Allergy".REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 2.1(2013):16-27. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。